Preclinical studies have shown that the vascular endothelial growth factor (VEGF) pathway is a critical signaling pathway in osteosarcoma, and VEGF receptor (VEGF-R) expression was correlated with an increased incidence of pulmonary metastasis and decreased event-free survival and OS [10, 11]. Here, VEGFA is linked to osteosarcoma.